Results 141 to 150 of about 78,679 (204)

Genomic analysis of the genetic background underlying Streptococcus pneumoniae beta-lactam nonsusceptibility in central Vietnam: increased beta-lactam nonsusceptibility and dynamics of the pbp2x gene. [PDF]

Trop Med Health
Fujii H, Sato M, Nguyen HAT, Vu HTT, Kakiuchi S, Dhoubhadel BG, Nakamura S, Motooka D, Ogura Y, Nakano S, Parry CM, Morimoto K, Yoshida LM, Anh DD, Hayashi T, Iida T, Ariyoshi K.   +16 more
europepmc   +1 more source

Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem [PDF]

, 2019
Blevins, Adam M, Juang, Paul, Kollef, Marin, Lashinsky, Jennifer N, McCammon, Craig, Micek, Scott   +5 more
core   +1 more source

Activity of cefepime/enmetazobactam against highly multidrug-resistant bacterial isolates recovered from war-associated wounds in Ukraine. [PDF]

JAC Antimicrob Resist
Boral J, Toft N, Baybes AE, Tellapragada C, Nazarchuk O, Fernandez C, Giske C, Riesbeck K.   +7 more
europepmc   +1 more source

A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME study. [PDF]

J Intensive Care Soc
Hansel J, Lain J, Erhieyovwe EO, Ismayilli A, Orr J, Keevil BG, Ogungbenro K, Dark PM, Felton TW.   +8 more
europepmc   +1 more source

Genomic profiling of extended-spectrum beta-lactamase-producing Escherichia coli isolated from poultry and poultry farm workers in Accra, Ghana. [PDF]

Sci Rep
Okyere IJ, Semevor GO, Ablordey A, Johnson S, Donkor ES.   +4 more
europepmc   +1 more source

Classification and applicability of new beta-lactamase inhibitors. [PDF]

Rev Esp Quimioter
Cercenado E, Candel FJ.
europepmc   +1 more source

Disruption of undecaprenyl phosphate recycling suppresses ampC beta-lactamase induction in Pseudomonas aeruginosa. [PDF]

PLoS Pathog
Klycheva K, Gyger J, Frund M, Torrens G, Cava F, Fumeaux C.   +5 more
europepmc   +1 more source

<i>In vivo</i> evolution of resistance to contemporary β-lactam/β-lactamase inhibitor combinations during treatment of a KPC-producing <i>Serratia marcescens</i> infection. [PDF]

Antimicrob Agents Chemother
Bailey DC, Castañeda-Barba S, Barry KE, Treerat P, Crawford MA, Hughes MA, Mathers AJ.   +6 more
europepmc   +1 more source

Longitudinal trends in antibiotic resistance of <i>Escherichia coli</i>: A 10-years retrospective analysis in a tertiary care hospital in Lahore, Pakistan. [PDF]

Pak J Med Sci
Fayyaz A, Iqbal MD, Ghafoor F.
europepmc   +1 more source